Published August 27, 2025 | Version v1
Presentation Open

Criterios actualizados para el diagnóstico y manejo de la Restriccion del Crecimiento Fetal

  • 1. Instituto de Investigación en Biomedicina (INBIOMED)
  • 2. Revista de la Facultad de Ciencias Médicas (Quito)
  • 3. ROR icon Central University of Ecuador
  • 4. Unidad de Salud

Description

La restricción del crecimiento fetal (RCF) es una condición asociada a elevada morbimortalidad perinatal y complicaciones a largo plazo, afectando al 10–15% de los embarazos. Su diagnóstico se basa en criterios ecográficos y Doppler, diferenciando entre formas tempranas (<32 semanas) y tardías (≥32 semanas). Las principales causas incluyen insuficiencia placentaria, trastornos maternos, anomalías fetales e infecciones. El manejo requiere vigilancia estrecha, balanceando el riesgo de muerte intrauterina frente a la prematuridad, con seguimiento Doppler seriado y eventual interrupción del embarazo. Postnatalmente, estos recién nacidos presentan mayor riesgo de complicaciones metabólicas, hematológicas, neurológicas y enfermedades crónicas en la adultez

Files

8. Dr. Vasco.pdf

Files (3.9 MB)

Name Size Download all
md5:d0aa5b5eadbac44093c53e4f5d5d814f
3.9 MB Preview Download

Additional details

References

  • Lees CC, Stampalija T, Baschat AA, et al. ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol 2020; 56: 298–312.
  • Gordijn SJ, Beune IM, Thilaganathan B, et al. Consensus definition of fetal growth restriction: a Delphi procedure. Ultrasound Obstet Gynecol 2016; 48: 333–339. Li Chi Chew, Obiyo O. Osuchukwu, Danielle J. Reed, Rita P. Verma. Fetal Growth Restriction. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;
  • Li Chi Chew, Obiyo O. Osuchukwu, Danielle J. Reed, Rita P. Verma. Fetal Growth Restriction. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Last Update: August 11, 2024.
  • American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 204: Fetal Growth Restriction. Obstet Gynecol 2019; 133: e97–109.
  • Bilardo CM, Hecher K, Visser GHA, et al. Severe fetal growth restriction at 26-32 weeks: key messages from the TRUFFLE study. Ultrasound Obstet Gynecol 2017; 50: 285–290.
  • Morris RK, et al. Investigation and Care of a Small‐for‐Gestational‐Age Fetus and a Growth Restricted Fetus (Green‐top Guideline No. 31). BJOG 2024; DOI: 10.1111/1471-0528.17814
  • Lees CC, Marlow N, van Wassenaer-Leemhuis A, et al. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet 2015; 385: 2162–2172. Morris RK, et al. Investigation and Care of a Small‐for‐Gestational‐Age Fetus and a Gr
  • Consenso Internacional SGA. International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood. Endocrine Reviews 2023; 44(3): 539–565.
  • Sharp A, Cornforth C, Jackson R, et al. Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial. Lancet Child Adolesc Health 2018; 2: 93–102.
  • Boers KE, Vijgen SM, Bijlenga D, et al. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ 2010; 341: c7087.
  • Savchev S, Figueras F, Sanz-Cortes M, et al. Evaluation of an optimal gestational age cut-off for the definition of early- and late-onset fetal growth restriction. Fetal Diagn Ther 2014; 36: 99–105.
  • Manning FA, Snijders R, Harman CR, et al. Fetal biophysical profile score. VI. Correlation with antepartum umbilical venous fetal pH. Am J Obstet Gynecol 1993; 169: 755–763.
  • Morales, Santiago Vasco, et al. "Factores de riesgo para bajo peso al nacer." Revista Latinoamericana de Perinatología 19.4 (2016): 237-242.